GLAXOSMITHKLINE PHARMACEUTICALS
Back to Income Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹3,822 Cr | ₹3,749 Cr | ₹3,454 Cr | ₹3,252 Cr | ₹3,278 Cr |
What is the latest Revenue of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹3,822 Cr |
| Mar2025 | ₹3,749 Cr |
| Mar2024 | ₹3,454 Cr |
| Mar2023 | ₹3,252 Cr |
| Mar2022 | ₹3,278 Cr |
How is Revenue of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,822 Cr | 1.93 | |
| Mar2025 | ₹3,749 Cr | 8.56 | |
| Mar2024 | ₹3,454 Cr | 6.21 | |
| Mar2023 | ₹3,252 Cr | -0.80 | |
| Mar2022 | ₹3,278 Cr | - | |
Compare Revenue of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹45,986.2 Cr | 1.7% | 10.2% | 6.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | 1.2% | 9.1% | 6.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹296,741.0 Cr | -2.7% | 22.2% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1% | 2% | 20.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,771.0 Cr | 1.5% | 13% | 12.1% | Stock Analytics | |
| CIPLA | ₹114,397.0 Cr | 1.7% | 7.8% | -7.3% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 1.7% |
10.2% |
6.5% |
| SENSEX | 1.4% |
12.4% |
-1.7% |
You may also like the below Video Courses